Embedded Files
amyloid and tau protein accumulation in the brain. “These scans can detect toxic brain proteins 15 to 20 years before they cause any symptoms,” notes Dr. Wisniewski. “It’s changing how we think about Alzheimer’s. One day, everyone will get brain scans at age 50 to see what preventive steps they should be taking—just like a colonoscopy.” NYU LANGONE MEDICAL CENTER / NEUROLOGY AND NEUROSURGERY / 2014 PAGE 31 CLINICAL CARE NYU Langone’s Division of Pediatric Neurosurgery was the first in New York City when it was established 30 years ago. Today, it is the most active practice in the metropolitan area, known internationally for its expertise at treating pediatric brain and spinal tumors, epileptic disorders, neurofibromatosis types 1 and 2, hydrocephalus, Chiari malformations, pediatric spine disorders, and other congenital and developmental conditions. Led by Jeffrey H. Wisoff, MD, professor of neurosurgery and pediatrics, director of pediatric neurosurgery, and the 2010 recipient of the Children’s Brain Tumor Foundation Pioneer Award, NYU Langone’s pediatric neurosurgeons perform more cranial brain tumor procedures annually than any other program in the New York metropolitan area, including challenging surgeries to remove complex tumors. Dr. Wisoff has pioneered techniques for the removal of deep seated brain tumors including craniopharyngiomas, suprasellar gliomas, pineal tumors, and thalamic gliomas. The pediatric neurosurgeons are also steadily expanding their use of minimally invasive endoscopic techniques for selected brain tumors, and are teaming with NYU Langone’s Laura and Isaac Perlmutter Cancer Center on novel treatments for brain malignancies, PEDIATRIC NEUROLOGY AND NEUROSURGERY Comprehensive Care for the Most Complex Pediatric Neurologic Conditions 2014 Highlights — • Performed more than 280 brain tumor, epilepsy, and spinal surgeries on children, as well as over 300 other pediatric and congenital neurosurgical procedures • Participated in cutting-edge clinical research on the genetic basis of autism, Tourette syndrome, epilepsy, and other childhood disorders such as a recent Phase II study on the use of sorafenib following surgery for recurrent low-grade astrocytoma.
Google Sites
Report abuse